AU Stock MarketDetailed Quotes

TYP Tryptamine Therapeutics Ltd

Watchlist

0.042
0.0000.00%

20min DelayMarket Closed Dec 12 16:00 AET

53.61MMarket Cap-0.46P/E (Static)

Tryptamine Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

Operating cash flow (direct method)

Cash income from operating activities

17.06%4.75M

3,542.65%4.06M

-79.89%111.51K

554.58K

Revenue from customers

524.00%618.57K

--99.13K

----

Income from government grants

45.22%62.9K

--43.31K

----

Other cash income from operating activities

3.93%4.07M

3,414.91%3.92M

-79.89%111.51K

--554.58K

----

Cash paid

31.65%-8.61M

-58.48%-12.59M

-8.68%-7.95M

-230.36%-7.31M

-2.21M

Payments to suppliers for goods and services

31.65%-8.61M

-23.25%-12.59M

-39.74%-10.22M

-230.36%-7.31M

---2.21M

Other cash payments from operating activities

----

--2.27M

----

Direct interest received

78.27%6.99K

-36.22%3.92K

-89.85%6.15K

110.43%60.58K

--28.79K

Operating cash flow

54.90%-3.85M

-8.93%-8.53M

-16.90%-7.83M

-206.55%-6.7M

---2.18M

Investing cash flow

Cash flow from continuing investing activities

77.60%-276.64K

31.34%-1.24M

-89.44%-1.8M

-10.59%-949.59K

-858.65K

Net PPE purchase and sale

75.41%-276.64K

30.77%-1.13M

-157.26%-1.63M

-18.39%-631.8K

---533.65K

Net intangibles purchas and sale

----

---325K

Net investment purchase and sale

----

32.12%-188.57K

---277.79K

----

Net other investing changes

----

-832.99%-109.95K

137.50%15K

---40K

----

Cash from discontinued investing activities

Investing cash flow

77.60%-276.64K

31.34%-1.24M

-89.44%-1.8M

-10.59%-949.59K

---858.65K

Financing cash flow

Cash flow from continuing financing activities

-51.24%918.56K

-90.86%1.88M

314.61%20.61M

-32.92%4.97M

7.41M

Net issuance payments of debt

-112.37%-337.56K

4,817.09%2.73M

---57.86K

----

Net common stock issuance

--1.57M

----

308.75%21.16M

-30.14%5.18M

--7.41M

Interest paid (cash flow from financing activities)

-192.68%-191.65K

---65.48K

----

---21.74K

----

Net other financing activities

84.06%-124.34K

-57.56%-779.85K

-167.76%-494.94K

---184.85K

----

Cash from discontinued financing activities

Financing cash flow

-51.24%918.56K

-90.86%1.88M

314.61%20.61M

-32.92%4.97M

--7.41M

Net cash flow

Beginning cash position

-61.91%4.85M

630.02%12.72M

-60.56%1.74M

8,332.96%4.42M

--52.4K

Current changes in cash

59.33%-3.2M

-171.76%-7.88M

510.30%10.98M

-161.28%-2.68M

--4.37M

Effect of exchange rate changes

-95.37%78

66.34%1.69K

--1.01K

----

End cash Position

-66.11%1.64M

-61.91%4.85M

630.02%12.72M

-60.56%1.74M

--4.42M

Free cash from

57.21%-4.13M

-2.10%-9.65M

-29.00%-9.45M

-140.82%-7.33M

---3.04M

Accounting Standards

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019
Operating cash flow (direct method)
Cash income from operating activities	17.06%4.75M	3,542.65%4.06M	-79.89%111.51K	554.58K
Revenue from customers	524.00%618.57K	--99.13K	----	----	----
Income from government grants	45.22%62.9K	--43.31K	----	----	----
Other cash income from operating activities	3.93%4.07M	3,414.91%3.92M	-79.89%111.51K	--554.58K	----
Cash paid	31.65%-8.61M	-58.48%-12.59M	-8.68%-7.95M	-230.36%-7.31M	-2.21M
Payments to suppliers for goods and services	31.65%-8.61M	-23.25%-12.59M	-39.74%-10.22M	-230.36%-7.31M	---2.21M
Other cash payments from operating activities	----	----	--2.27M	----	----
Direct interest received	78.27%6.99K	-36.22%3.92K	-89.85%6.15K	110.43%60.58K	--28.79K
Operating cash flow	54.90%-3.85M	-8.93%-8.53M	-16.90%-7.83M	-206.55%-6.7M	---2.18M
Investing cash flow
Cash flow from continuing investing activities	77.60%-276.64K	31.34%-1.24M	-89.44%-1.8M	-10.59%-949.59K	-858.65K
Net PPE purchase and sale	75.41%-276.64K	30.77%-1.13M	-157.26%-1.63M	-18.39%-631.8K	---533.65K
Net intangibles purchas and sale	----	----	----	----	---325K
Net investment purchase and sale	----	----	32.12%-188.57K	---277.79K	----
Net other investing changes	----	-832.99%-109.95K	137.50%15K	---40K	----
Cash from discontinued investing activities
Investing cash flow	77.60%-276.64K	31.34%-1.24M	-89.44%-1.8M	-10.59%-949.59K	---858.65K
Financing cash flow
Cash flow from continuing financing activities	-51.24%918.56K	-90.86%1.88M	314.61%20.61M	-32.92%4.97M	7.41M
Net issuance payments of debt	-112.37%-337.56K	4,817.09%2.73M	---57.86K	----	----
Net common stock issuance	--1.57M	----	308.75%21.16M	-30.14%5.18M	--7.41M
Interest paid (cash flow from financing activities)	-192.68%-191.65K	---65.48K	----	---21.74K	----
Net other financing activities	84.06%-124.34K	-57.56%-779.85K	-167.76%-494.94K	---184.85K	----
Cash from discontinued financing activities
Financing cash flow	-51.24%918.56K	-90.86%1.88M	314.61%20.61M	-32.92%4.97M	--7.41M
Net cash flow
Beginning cash position	-61.91%4.85M	630.02%12.72M	-60.56%1.74M	8,332.96%4.42M	--52.4K
Current changes in cash	59.33%-3.2M	-171.76%-7.88M	510.30%10.98M	-161.28%-2.68M	--4.37M
Effect of exchange rate changes	-95.37%78	66.34%1.69K	--1.01K	----	----
End cash Position	-66.11%1.64M	-61.91%4.85M	630.02%12.72M	-60.56%1.74M	--4.42M
Free cash from	57.21%-4.13M	-2.10%-9.65M	-29.00%-9.45M	-140.82%-7.33M	---3.04M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Heat List

Overall

No Data